Location History:
- Parkton, MD (US) (1989)
- Wallingford, PA (US) (1976 - 1990)
Company Filing History:
Years Active: 1976-1990
Title: The Innovative Work of George R. Huggins
Introduction
George R. Huggins, an influential inventor based in Wallingford, PA, has made significant contributions to the field of reproductive health through his pioneering innovations. With a total of seven patents to his name, Huggins has focused on the nuances of hormonal monitoring in women to provide more accurate indicators of fertility.
Latest Patents
Among Huggins' latest inventions are two notable patents centered on the monitoring of axillary androstenol and dehydroepiandrosterone sulfate to determine the onset of the fertile period in human females. His methods involve analyzing the variations in these hormone concentrations throughout the menstrual cycle. A significant peak in either compound's concentration after menstruation serves as an indicator of approaching ovulation. This innovation not only assists in predicting fertility but also helps in implementing effective contraceptive measures to avoid unwanted pregnancies.
Career Highlights
Huggins’ career includes affiliation with prominent research institutions such as the University of Pennsylvania and the Monell Chemical Senses Center, where he has conducted extensive research on chemical senses and hormonal influences. His work has had a profound impact on both academic and practical applications in reproductive health.
Collaborations
Throughout his career, Huggins has collaborated with esteemed colleagues, including George Preti and Winnifred B. Cutler. These partnerships have enriched his research and contributed to the successful development of his patented innovations.
Conclusion
George R. Huggins stands out as an innovative mind in the field of reproductive health. His patented methods of detecting the onset of fertility through hormonal monitoring hold promise for both individual reproductive planning and broader implications for family planning methods. As he continues to push the boundaries of innovation, Huggins remains a vital figure in the domain of reproductive health technologies.